Floatz logo

CHLOROPTIC-P S.O.P. COMPONENT PREDNISOLONE

T Cell Lymphoma

Won Seog KimSmall moleculePhase 1/2Active
CCC
55/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
44/ 100
Competitive Position
89/ 100

Competitive context

9 Active assets in the T Cell Lymphoma cohort.

Asset / SponsorPhaseRating
(+)-VINCRISTINE
Dizal Pharmaceuticals
Phase 3BB
cd19-ucart
Beijing GoBroad Hospital
Phase 1/2B
Tenalisib
Rhizen Pharmaceuticals SA
Phase 1/2B
Fostamatinib Disodium
Rigel Pharmaceuticals
Phase 2B
MOGAMULIZUMAB
Yale University
Phase 2CCC

View all 20 →

Same molecule, other indications

CHLOROPTIC-P S.O.P. COMPONENT PREDNISOLONE is also rated in:

infantile spasmsDormant
BBB
Indicative ·
79 / 100
View asset →
non-Hodgkin lymphomaDormant
BBB
Indicative ·
74 / 100
View asset →
castration-resistant prostate carcinomaDormant
BBB
Indicative ·
72 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →